Medicine
Grafapex 1000 mg/g powder for injection
Grafapex 1000 mg/g powder for injection is a prescription medicine containing Treosulfan for intravenous use, marketed by Medexus Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). (Excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Treosulfan
- Brand
- Grafapex
- Strength
- 1000 mg/g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Medexus Pharma
- Manufacturer
- Medexus Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). (Excursions permitted between 15°C and 30°C) GRAFAPEX is a hazardous drug.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01AB02 Treosulfan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 January 2025
- Identifiers
- RxCUI 2703570, 2703575, 2703577 +1DailyMed set ID 2d06b03c-17aa-0492-e063-6294a90abd8fNDC 59137-335, 59137-365Application NDA214759
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 g in 1 vial | 59137-335-01 | Medexus Pharma | 28 January 2025 |
| 1 vial in 1 carton / 5 g in 1 vial | 59137-365-01 | Medexus Pharma | 28 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Treosulfan is a prescription medicine indicated for use in combination with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult, among other approved uses. MedsAcross supplies Treosulfan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TreosulfanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- GRAFAPEX prescribing information (Medexus Pharma) · U.S. National Library of Medicine, DailyMed
- Trecondi: European public assessment report (EPAR) · European Medicines Agency
Need Grafapex 1000 mg/g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.